Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide With and Without Exercise in Obesity
NCT07091500Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2025
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Randomised trial of semaglutide in obesity (2 arms), sponsored by Washington University School of Medicine. Primary endpoints: Physical function at 104 weeks and Body composition at 104 weeks. Started Aug 2025; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07091500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07091500.